FDA Brief

Company record

Vivera Pharmaceuticals, Inc.

2 FDA warning letters since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Vivera Pharmaceuticals, Inc..

Warning letters

  1. Vivera Pharmaceuticals, Inc.

    FDA warned Vivera Pharmaceuticals for selling unapproved COVID-19 antigen test kits online.

    High risk
  2. Vivera Pharmaceuticals, Inc.

    Vivera Pharmaceuticals sold a COVID-19 home specimen collection kit directly to consumers without FDA approval, clearance, or authorization.

    High risk